CClinicalTrials.gg
Not yet recruitingNCT07242924ERASUpdated Nov 21, 2025

Enhanced Recovery After Emergency Cesarean Section: A Comparative Study Assessing Postoperative Recovery and Outcomes

An observational study in ERAS and Cesarean Section Pain, sponsored by Assiut University. Not yet recruiting. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Cesarean section (CS) remains one of the most common major surgical procedures worldwide, with emergency CS accounting for approximately 30% of cases. Emergency CS presents unique challenges including increased maternal stress, higher complication rates, and prolonged recovery compared to elective procedures . Enhanced Recovery After Surgery (ERAS) protocols offer a promising approach to optimize outcomes in this population.

Originally developed for colorectal surgery, ERAS principles have been successfully adapted to obstetric practice over the past decade. These evidence-based protocols emphasize multimodal interventions including preoperative counseling, optimized analgesia, early mobilization, and timely nutrition. In obstetrics, ERAS implementation has demonstrated reduced length of stay, decreased opioid use, and improved patient satisfaction for elective CS .

Application of ERAS to emergency CS requires special considerations due to the urgent nature of the procedure. Modified protocols focus on rapid preoperative assessment, regional anesthesia with intrathecal opioids, and immediate postoperative care initiation . Emerging evidence suggests these adaptations maintain benefits while accommodating time constraints . Key outcomes include reduced postoperative pain, earlier return of bowel function, and improved breastfeeding rates .

Current research demonstrates ERAS protocols can be safely implemented in emergency CS with proper staff training and institutional support . Ongoing studies continue to refine optimal practices, particularly regarding fluid management and thromboprophylaxis . As evidence accumulates, standardized guidelines for emergency CS ERAS pathways are expected to emerge .

Read the detailed description

The study is conducted on two phases. First phase study tools will be prepared. This is followed by the first and second audit cycles, preparatory phase is done to assess the intra-operative and post-operative care of women undergoing emergency cesarean section using the guidelines of Enhanced recovery after Surgery society. The quality of recovery score-11 translated into arabic. Permission is sought from adminstritive authorities.

First audit cycle : compliance with intraoperative measures is obtained by direct observation . post-operative information will be obtained by patient interview and record audit. The quiality of recovery will be assessed just before discharge using the quality of recovery score (ObsQoR-11).

Corrective action : gaps identified by first audit cycle is translated into defined corrrective measures.

02

Conditions studied

  • ERAS
  • Cesarean Section Pain

Keywords

  • ERAS
  • ERAS, emergency cs
03

In context

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

Pregnant patients admitted to Woman's Health hospital, Assiut university labor ward and post-partum.

Inclusion criteria

  • singleton pregnancy who undergoing emergency cesarean section after 34weeks and accepting to be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Pregnant woman who had previous rupture uterus.
  • Other medical disorders as hypertensive disorder during pregnancy, cardiac disease.
  • Intra-operative complications necessitating changes in post-operative care e.g. bowel injury, urinary tract injury.
  • Hemodynamically unstable (post-partum hemorrhage)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Enhanced Recovery After Surgery protocol for emergency cesarean section

    Application of ERAS protocol delivered perioperatively and postoperatively as per institutional ERAS guidelines.

06

What researchers measure

Primary outcomes

  1. assess the obstetric ObQOR11scrore at 12 hours and 24 hours post-operative

    A data collection tool will be prepared for the study. After screening for eligibility, demographic factors, obstetric history. weight and gain, quality of previous cesarean scar if any, hemoglobin will be assessed for all patients. Observation of the outcomes will be recorded in the first phase of the study using a structured proforma and the Arabic version of ObQOR-11 score. Secondary outcomes measures include first oral intake, first abulation, first urination after catheter removal, passage of flatus and pain visual analog scale every 4 hours till discharge.

    Time frame: From enrollment till discharge after 24 hours.

Secondary outcomes

  1. Secondary outcome

    Time to first oral intake

    Time frame: During hospital stay up to discharge, typically within 24-48 hours postoperative

  2. Secondary outcome

    Time to passage of flatus

    Time frame: During hospital stay up to discharge, typically within 24-48 hours postoperative

  3. Secondary outcome

    Time to first ambulation

    Time frame: During hospital stay up to discharge, typically within 24-48 hours postoperative

  4. Secondary outcome

    Time to first urination after catheter removal

    Time frame: During hospital stay up to discharge, typically within 24-48 hours postoperative

  5. Secondary outcome

    Pain visual analog scale (VAS) scores every 4 hours until discharge

    Time frame: During hospital stay up to discharge, typically within 24-48 hours postoperative

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07242924
Lead sponsor
Assiut University
Responsible party
Mahmoud Mohamed Abbady Hussein (Resident physician, Assiut University) — Principal investigator
First posted
Nov 21, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Dec 1, 2028 (estimated)
Last update
Nov 21, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion